Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

A&M Labor fur Analytik und Metabolismusforschung Service GmbH

A&M Labor fur Analytik und Metabolismusforschung Service GmbH is listed as a small business research supplier in the Scientist.com network, with 2 sites in 1 country and 2 service areas.

View A&M Labor fur Analytik und Metabolismusforschung Service GmbH on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Antibodies

  • Antibody Products Purchase antibody, antibody pair kit or ELISA kit.
  • Antibody Sequencing Sequence cDNA encoding variable heavy (VH) and variable light (VL) domains of a hybridoma cell line.
  • Antibody-Drug Conjugation Improve therapeutic properties of an antibody or drug by joining them together.

Biomarkers

  • Antimicrobial Effectiveness Testing Measure the efficacy of anti-microbial preservatives added to a product.
  • Autoantibody Testing Screen for the presence of an autoimmune disorder.
  • Basic Metabolic Profiling Set up assays that monitor drug metabolite formation after administration of drug to an animal model or patient.
  • Biomarker Analytical Validation Assess and optimize the characteristics of a candidate biomarker to ensure reproducibility and consistency.
  • Biomarker Services Evaluating normal/abnormal biological conditions and characteristics within the body
  • Cell Viability Measure changes in cell number, cell division, DNA content or a cell metabolism marker such as ATP levels.
Show all 11 in Biomarkers 5 more
  • Cerebrospinal Fluid Analysis Use CSF to detect or monitor a variety of nervous system diseases or conditions.
  • Cytokine Release Assay Use in vivo or in vitro assays to detect unregulated or excessive release of pro-inflammatory cytokines.
  • Insulin Autoantibodies (IAA) Testing Detect the risk or presence of type 1 diabetes in early childhood.
  • Lipid Profiling Use quantitative analysis of blood lipid components to assess cardiac risk.
  • Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.

Chemical and Compound Analysis

  • Amino Acid Analysis (AAA) Determine protein quantities, relative compositions and amino acid content profiles.
  • API Physical Characteristics Characterize physical and chemical properties of new drug molecules to develop safe, effective, and stable dosage forms.
  • Chemical Stability Measure the stability of small molecules in solution.
  • Dissolution Profiling Measure release of API from formulation (tablet or capsules) under GMP guidelines.
  • Dynamic Light Scattering Determine the size of particles and extent of molecular aggregation in a suspension.
  • Electrophoresis Separate nucleic acids or proteins based on physical properties such as charge or mass.
Show all 22 in Chemical and Compound Analysis 16 more
  • Excipient Compatibility Test excipients for drug formulation, effects of temperature, time, humidity, pH and light exposure as well as excipient release.
  • GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Headspace Gas Chromatography Analyze volatile organic compounds (VOCs) partitioned above the liquid/solid phase of a sample.
  • High Resolution MS Elucidate the sequence and structure of peptides, proteins, biomarkers and organic compounds.
  • Ion Exchange Chromatography Separate and detect analytes.
  • Liquid Chromatography Separate substances using a mobile and stationary phase.
  • Non GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Particle Size Analysis Measure particle size distribution and characterize particle size, porosity and composition.
  • Photostability Measure drug degradation rates after exposure to various light sources.
  • Protein Binding HPLC Uses high pressure liquid chromatography to separate protein-drug complexes.
  • Protein Separation and Detection Separate proteins based on properties such as solubility, adsorption or size differences.
  • Sample Bioanalysis Determination of concentration of an analyte in biological sample.
  • Secondary Ion Mass Spectrometry Detect trace level impurities and obtain elemental or molecular chemical data for solid sample surfaces.
  • Size Exclusion Chromatography Separate and identify analytes based on their molecular size.
Show all 97 services 82 more

Chemistry, Manufacturing and Controls (CMC)

  • API Stress Testing Studies Develop analytical methods to predict stability problems and identify degradation products/pathways under forced degradation conditions.
  • API/ Excipients Compatibility Studies Delineate real and possible interactions between potential formulation excipients and the API as an important risk reduction exercise early in formulation development.
  • Chemistry Manufacturing Controls Access contract manufacturing and regulatory guidance in setting specifications and drug dosage formulations.
  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services
  • Drug Product Stability Use accelerated stress conditions to determine degradation pathways and identify manufacturing issues.
  • Forced Degradation Run light, heat, humidity, acid hydrolysis and oxidation tests to evaluate substance degradation.

Clinical Trials

  • Bioequivalence Studies Assess the expected biological equivalence of two proprietary preparations of a drug.

Discovery Chemistry

  • Extractable and Leachable Assessment Quantify potential impurities from container closures & packaging.
  • Impurity Synthesis Use high resolution MS or NMR to eliminate intermediates or organic byproducts and determine impurity content.
  • LCMS Analysis Physically separate substances using liquid chromatography and mass spectrometry.
  • Method Development and Validation Develop and validate methods for synthesis and scale up of drug candidates.

Effectiveness

  • Bioequivalence Studies for Veterinary Drugs Assess the expected biological equivalence of two proprietary preparations of a veterinary drug.

General in vivo Toxicology

  • Single Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by a single administration in a 7 day period.
  • Single Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by a single administration in a 7 day period.

In Vitro ADME

  • Conjugate Detection Measure the conjugation of endogenous small molecules to drug candidates after in vivo administration.
  • CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
  • CYP Inhibition Assay Assess the inactivation and inhibition of cytochrome P450 (CYP450) in microsomes isolated from primary human hepatocytes or liver.
  • Cytochrome P450s Assess the inhibition or induction of the various isozymes of cytochrome P450s by drug candidates.
  • Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
  • Isotopic Labeling Track labeled isotopes through a metabolic pathway or cell by measuring mass, vibrational mode or radioactive decay.
Show all 24 in In Vitro ADME 18 more
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
  • Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
  • Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
  • Metabolite Generation Analyze the formation of drug metabolites after administration of drug to an animal model or patient.
  • Metabolite Identification Identify drug metabolites that are formed after administration of drug to an animal model or patient.
  • Metabolite Identification and Profiling Estimate drug candidate metabolites after administration of drug to an animal or human subject.
  • Metabolite Quantification Quantify drug metabolites formed after drug administration to an animal model or patient.
  • Metabolite Structural Elucidation Use analytical tools to characterize metabolite structure.
  • Metabolite Synthesis Synthesize drug metabolites that are formed after administration of drug to an animal model or patient.
  • No Label Methods Use mass spectrometry to detect and identify non-radiolabeled drug intermediates in pre-clinical samples.
  • Non Isotopic Labeling Track unlabeled macromolecules through a metabolic pathway or cell.
  • Phase I Metabolism Use enzymes such as cytochrome P450 oxidases to introduce reactive or polar groups into xenobiotics.
  • Phase II Metabolism Use transferase enzymes such as glutathione S-transferases to conjugate phase I xenobiotics to polar compounds.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Protein Binding Ultrafiltration Measure the rate at which unbound drug passes through a dialysis membrane that models epithelial barrier pore size.
  • Radiolabeled Tracers Use radiolabeled drug metabolites as radiotracers for measuring desired physiological processes.
  • Reactive Metabolite Ensure that your drug candidate is not generating toxic reactive metabolites in vivo.
  • Red Blood Cell (RBC) Partitioning (Blood/Plasma Ratio) Measure the distribution of a compound between red blood cells and plasma.

In Vitro Assays

  • Apoptosis Assays Detect apoptotic events that lead to programmed cell death.
  • Apoptotic Cell Staining Detect apoptotic cells in culture.
  • Glucose Uptake Measure glucose uptake in cultured cells using GLUT4 signaling assays.
  • Oxidative Burst Examine the release of reactive oxygen species (ROS) from neutrophils and other immune cells.

In Vivo Pharmacokinetics

  • In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
  • In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
  • Mass Balance Elucidate excretory pathways and organ distribution of a parent drug and metabolites
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
Show all 8 in In Vivo Pharmacokinetics 2 more
  • Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
  • Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.

Protein Sciences

  • Carbohydrate Structure Characterization Use analytical tools to elucidate carbohydrate structure and physiochemical properties.
  • N-terminal Sequencing Determine the amino acid sequence of an intact protein from its N-terminus.
  • Protein Identification Uncover or confirm the identity of a protein.
  • Protein Post-translational Modification Analysis Measure glycosylation, phosphorylation, sulfation, ubiquitination, methylation and acetylation.

Target Animal and Human Food Safety

  • Toxicokinetic Analysis Determine the drug concentration at which off-target or toxic effects occur.

Testing Services

  • Accelerated Stability Determine shelf life of drug formulations by comparing API breakdown at elevated temperature.
  • Elevated Temperature Stability Determine the stability of a product at elevated temperature.
  • Freeze-Thaw Testing Use freeze-thaw cycling to measure the long-term durability of cosumer products.
  • Package Compatibility Tests Ensure that the consumer product is not adversely affected by the package components and vice versa.
  • Real-time Stability Test Assure stability and physical integrity of consumer products in real-time conditions.

Other services

  • New Request  

Service areas:

Chemistry DMPK

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • Germany Bergheim 2 sites

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

A&M is focused in offering their expertise in pharmaceutical analysis, mass spectrometry, metabolite identification, and bioanalysis services.

Website
am-labor.de/de/leistungen/bioanalytik

Source: Scientist.com supplier network, written by the supplier

Get the A&M Labor fur Analytik und Metabolismusforschung Service GmbH report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with A&M Labor fur Analytik und Metabolismusforschung Service GmbH on Scientist.com

For prices, more details, or to contact A&M Labor fur Analytik und Metabolismusforschung Service GmbH, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.